Remedee Labs
Description
Remedee Labs is a health tech start-up dedicated to improving the quality of life for people with chronic pain. Our holistic, patient-centric solution combines our breakthrough technology (the first individual stimulator of endorphins through millimeter waves therapy) with personalized coaching, a digital platform and data. As an overview, Remedee has :
- 2 positive clinical studies in fibromyalgia (a women health pathology with no approved solution to date) and osteoarthritis (rheumatology), and a pipeline of other potential indications
- CE Medical (MDR) in both indications expected shortly ; reimbursement file to be submitted in Q4 24 in France
- FDA's Breakthrough Device Designation for fibromyalgia
- ca. 3000 active suscribers (> 1M€ ARR) with valuable real-world data
- a strategic partnership with GENERALI (also investor & Board member), reimbursing and promoting our solution with employers
- a strategic partnership with UPSA, promoting our solution with 20.000 physicians in France.
We are looking for investors and strategic partners for the next phase of our development.
